The Gross Law Firm Notifies Shareholders of Moderna, Inc.(MRNA) of a Class Action Lawsuit and an Upcoming Deadline

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Moderna, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its respiratory syncytial virus vaccine, mRNA-1345, during the class period from January 18, 2023, to June 25, 2024 [1][2]. Group 1 - The class action alleges that mRNA-1345 was less effective than Moderna had claimed, leading to overstated clinical and commercial prospects [1]. - The lawsuit claims that the company's public statements were materially false and misleading throughout the relevant period [1]. - Shareholders who purchased shares during the specified class period are encouraged to register for potential lead plaintiff appointment, with a deadline set for October 8, 2024 [2]. Group 2 - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3]. - Participation in the class action has no cost or obligation for shareholders who register [2].